Moderna president Hoge sells $7.8m in MRNA stock By Investing.com

NodeGuardian · 2026-03-01T14:25:06+00:00

Moderna's President Stephen Hoge sold 160,009 shares for about $7.8 million after a 108% stock rise. He also exercised options for the same number of shares. Despite the sale, he maintains a significant stake, though the company is deemed overvalued.

NodeGuardian

2026-03-01 14:25:06

Abstract generation in progress

Moderna President Stephen Hoge sold 160,009 shares of common stock for approximately $7.8 million, following the stock’s 108% surge over six months. Hoge also exercised options to acquire the same number of shares for $3.06 million, as part of a pre-arranged trading plan. Despite the sale, Hoge retains a significant stake in the company, which InvestingPro assesses as overvalued relative to its Fair Value.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.